IMA
Price
$14.23
Change
+$0.15 (+1.07%)
Updated
Aug 22 closing price
Capitalization
159.12M
75 days until earnings call
SLXN
Price
$7.18
Change
+$0.38 (+5.59%)
Updated
Aug 22 closing price
Capitalization
5.25M
Interact to see
Advertisement

IMA vs SLXN

Header iconIMA vs SLXN Comparison
Open Charts IMA vs SLXNBanner chart's image
ImageneBio
Price$14.23
Change+$0.15 (+1.07%)
Volume$2.69K
Capitalization159.12M
Silexion Therapeutics
Price$7.18
Change+$0.38 (+5.59%)
Volume$26.38K
Capitalization5.25M
IMA vs SLXN Comparison Chart in %
Loading...
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMA vs. SLXN commentary
Aug 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a StrongBuy and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 24, 2025
Stock price -- (IMA: $14.23 vs. SLXN: $7.18)
Brand notoriety: IMA and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 1% vs. SLXN: 29%
Market capitalization -- IMA: $159.12M vs. SLXN: $5.25M
IMA [@Biotechnology] is valued at $159.12M. SLXN’s [@Biotechnology] market capitalization is $5.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMA is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • IMA’s TA Score: 4 bullish, 5 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than IMA.

Price Growth

IMA (@Biotechnology) experienced а +0.21% price change this week, while SLXN (@Biotechnology) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

IMA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMA($159M) has a higher market cap than SLXN($5.25M). IMA YTD gains are higher at: 767.683 vs. SLXN (-76.186).
IMASLXNIMA / SLXN
Capitalization159M5.25M3,027%
EBITDAN/A-17.81M-
Gain YTD767.683-76.186-1,008%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A3.47M-
Total DebtN/A3.7M-
TECHNICAL ANALYSIS
Technical Analysis
IMASLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
40%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
20%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 27 days ago
51%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMBLF16.071.53
+10.55%
Brambles, Ltd.
REEMF1.110.07
+6.73%
Rare Element Resources Ltd.
PREKF17.510.05
+0.27%
Prairiesky Royalty Ltd.
LFGP14.00N/A
N/A
Ledyard Financial Group, Inc.
MKRIF0.09N/A
-0.64%
Melkior Resources Inc.

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
+1.07%
CELC - IMA
86%
Closely correlated
+4.05%
NEVPF - IMA
66%
Loosely correlated
N/A
MRSN - IMA
65%
Loosely correlated
-4.44%
SLXN - IMA
59%
Loosely correlated
+5.59%
TRML - IMA
24%
Poorly correlated
+1.08%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+5.59%
IMA - SLXN
63%
Loosely correlated
+1.07%
CELC - SLXN
50%
Loosely correlated
+4.05%
MRSN - SLXN
43%
Loosely correlated
-4.44%
CHRS - SLXN
26%
Poorly correlated
+8.85%
QSI - SLXN
25%
Poorly correlated
+2.70%
More